Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 USD | -0.43% | +3.56% | -29.01% |
May. 13 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
May. 08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.01% | 195M | |
+15.54% | 77.63B | |
+12.05% | 8.78B | |
+58.17% | 4.93B | |
-14.94% | 4.79B | |
-.--% | 3.8B | |
+21.94% | 2.46B | |
-26.63% | 2.2B | |
+16.75% | 2.1B | |
-37.97% | 1.96B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Canaccord Genuity Adjusts Price Target on Zevra Therapeutics to $20 From $19, Keeps Buy Rating